eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (HES), and has also shown efficacy in a phase 3 trial in chronic obstructive pulmonary disease (COPD).
eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. The drug remains one of GSK's top products, with sales of £856 million ($1.1 billion) in the first half of this year ...
Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...
Why are the two often so disconnected? And what role can technology play in integrating them? A new CMS accountable care program aims to drive progress, and one expert explains what it means for ...
Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Approval based on phase 3 data showing significantly more children aged one to 11 years ...
Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis | Regulatory News ...
Nov. 7, 2024 — Researchers have developed an innovative technique to search for black hole light echoes. Their novel method, which will make it easier for the mass and the spin of black holes to ...
Nov. 4, 2024 — The Amazon region is a global hotspot of biodiversity and plays a key role in the climate system because of its ability to store large amounts of carbon and its influence on the ...
Internal political squabbles — and the fallout from a global backlash to inflation, immigration and ruling elites — are hobbling Germany and France. By Jim Tankersley and Aurelien Breeden ...
The move comes just before a Biden administration deadline for Israel to deliver more aid to the enclave or risk a cutoff of military supplies. By Hiba Yazbek A day after the prime minister of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback